You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

Atezolizumab with BCG before surgery (neoadjuvant) for treating non-muscle-invasive bladder cancer [ID6667]

  • Awaiting development
  • Reference number: GID-TA11884
  • Expected publication date: TBC
  • Project information
  • Project documents

13562-Atezolizumab-Bacillus-Calmette-Guerin-for-Bladder-Cancer-V1.0-SEP2025-NON-CONF-.pdf

Back to top